NCT01326325View on ClinicalTrials.gov

Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

June 30, 2013

Conditions
Pain
Interventions
DRUG

Ketamine

Drip continues of ketamine in intravenous injection included posology enters 0,5mg/kg /day and 2mg/kg/day during 4 days

DRUG

NaCl

Drip continues of NaCl 0,9% in intravenous injection during 4 days

Trial Locations (1)

75012

Center of Evaluation and Treatment of the pain - Saint-Antoine Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01326325 - Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment | Biotech Hunter | Biotech Hunter